50 related articles for article (PubMed ID: 15792818)
1. Exploring causality of the association between smoking and Parkinson's disease.
Gallo V; Vineis P; Cancellieri M; Chiodini P; Barker RA; Brayne C; Pearce N; Vermeulen R; Panico S; Bueno-de-Mesquita B; Vanacore N; Forsgren L; Ramat S; Ardanaz E; Arriola L; Peterson J; Hansson O; Gavrila D; Sacerdote C; Sieri S; Kühn T; Katzke VA; van der Schouw YT; Kyrozis A; Masala G; Mattiello A; Perneczky R; Middleton L; Saracci R; Riboli E
Int J Epidemiol; 2019 Jun; 48(3):912-925. PubMed ID: 30462234
[TBL] [Abstract][Full Text] [Related]
2. Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
Rose KN; Schwarzschild MA; Gomperts SN
Mov Disord; 2024 Feb; 39(2):267-272. PubMed ID: 38226487
[TBL] [Abstract][Full Text] [Related]
3. Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease.
Gabbert C; König IR; Lüth T; Kolms B; Kasten M; Vollstedt EJ; Balck A; Grünewald A; Klein C; Trinh J
J Neurol; 2022 Aug; 269(8):4195-4203. PubMed ID: 35235000
[TBL] [Abstract][Full Text] [Related]
4. Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice.
García-Montes JR; Solís O; Enríquez-Traba J; Ruiz-DeDiego I; Drucker-Colín R; Moratalla R
Mol Neurobiol; 2019 Jun; 56(6):4037-4050. PubMed ID: 30259400
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.
Barreto GE; Iarkov A; Moran VE
Front Aging Neurosci; 2014; 6():340. PubMed ID: 25620929
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.
Kawamata J; Suzuki S; Shimohama S
Ther Adv Chronic Dis; 2011 May; 2(3):197-208. PubMed ID: 23251750
[TBL] [Abstract][Full Text] [Related]
7. Association between comorbidity and clinical characteristics of MS.
Marrie RA; Horwitz RI; Cutter G; Tyry T; Vollmer T
Acta Neurol Scand; 2011 Aug; 124(2):135-41. PubMed ID: 20880264
[TBL] [Abstract][Full Text] [Related]
8. Smoking status over two years in patients with multiple sclerosis.
Marrie RA; Cutter G; Tyry T; Campagnolo D; Vollmer T
Neuroepidemiology; 2009; 32(1):72-9. PubMed ID: 19001800
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Parkinson's disease.
Kasten M; Chade A; Tanner CM
Handb Clin Neurol; 2007; 83():129-51. PubMed ID: 18808913
[TBL] [Abstract][Full Text] [Related]
10. Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: a cautionary tale.
Wilk JB; Lash TL
Emerg Themes Epidemiol; 2007 Apr; 4():1. PubMed ID: 17408493
[TBL] [Abstract][Full Text] [Related]
11. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
[TBL] [Abstract][Full Text] [Related]
12. [Levodopa and cognitive disorders in Parkinson's disease].
Leiva-Santana C; Alvarez-Saúco M
Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
[TBL] [Abstract][Full Text] [Related]
13. Management for motor and non-motor complications in late Parkinson's disease.
Chan DK; Cordato DJ; O'Rourke F
Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
[TBL] [Abstract][Full Text] [Related]
14. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
De Reuck J; De Weweire M; Van Maele G; Santens P
J Neurol Sci; 2005 Apr; 231(1-2):35-9. PubMed ID: 15792818
[TBL] [Abstract][Full Text] [Related]
15. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
[TBL] [Abstract][Full Text] [Related]
16. Levodopa induced motor complications in Thai Parkinson's disease patients.
Kulkantrakorn K; Tiamkao S; Pongchaiyakul C; Pulkes T
J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
